Followers | 32 |
Posts | 2740 |
Boards Moderated | 0 |
Alias Born | 01/17/2014 |
Sunday, June 10, 2018 8:26:05 PM
In energy storage, there is a tremendous demand for improved performance in a multi-billion-dollar market. When one combines EVs, distributed renewables, and personal electronics, it reaches the tens of billions. That demand for increased performance has resulted in billions being spent right now on innovation.
We believe CHS will catalyze new performance innovations in energy storage, and several of our customers think this as well. Our stated goal is to achieve approximately 200% improvement in performance, however, we expect these increases to be incremental, such as 30% improvements, then another 30% more, and so on. Cost will be determined by the markets, as there will be higher prices paid for larger performance initially (likely EV), and then filter into distributed renewables, and finally into commodity electronics. Of course, that changes if consumers are willing to pay $200 more for a smartphone that lasts several days on a single charge.
SEVERAL CUSTOMERS ARE WITH CORETEC IN BELIEVING THAT CHS WILL BE THE CATALIST FOR BETTER PERFORMANCE ...COMING SOON THATS HUGE !!!
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM